Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET
Recruiting
Observational Study
Lung Cancer
Lymphoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Academisch Ziekenhuis Maastricht · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to evaluate the use of new method to quantify the amount of sugar a tumor consumes using PET/CT. The main questions it aims to answer are:
* Is the new quantification method superior with respect to the method currently used in the clinic?
* Does the new quantification method provide accurate assessment of the sugar consumption of tumours?
Participants who will undergo …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients who receive an 18F FDG PET/CT scan as part of standard care
* Be competent and be 18 years of age or older
Exclusion Criteria:
* Diabetes (fasted blood glucose \> 7 mmol/L)
* Not fasted \> 4 hours
* Physical exercise within 24 hours
* Earlier treatment for carcinoma…
Contacts